1α-hydroxy-vitamin D2: A new look at an 'old' compound

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 153-157

  Coburn, J W ^a   Tan Jr , A U ^b   Levine, B S ^b   Mazess, R B ^b   Kyllo, D M ^b   Knutson, J C ^b   Bishop, C W ^b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

1 hydroxy vitamin D2; Haemodialysis; Hyperparathyroidism; Renal osteodystrophy; Vitamin D

Indexed keywords

CALCITRIOL; DOXERCALCIFEROL;

BONE ATROPHY; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HYPERCALCEMIA; HYPERCALCIURIA; OSTEOPENIA; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

EID: 0029736643     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.153     Document Type: Conference Paper

References (24)

1. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986; 78: 1296-1301
2. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980-991
3. 2D3 and 22-oxacalcitriol on phosphate and calcium metabolism. Kidney Int 1993; 43: 561-566
4. Kubrusly M, Gagné E-R, Ureña P et al. Effect of 22-oxacalcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism. Kidney Int 1993; 44: 551-556
5. Morii H, Miura Y, Nagura Y et al. Effect of hexafluorocalcitriol on renal osteodystrophy in hemodialysed patients. Nephrol Dial Transplant 1995; in press
6. 2, suppresses PTH secretion in uremic rats in the absence of hypercalcemia. J Bone Miner Res 1995; 10 (Suppl 1): S116 (Abstract)
7. 3 from the skin of rats exposed to ultraviolet irradiation. Biochemistry 1979; 18: 1003-1008
8. Bills CE. The vitamin D group (Sections Ii-V). In: Sebrell WH Jr, Harris RS, eds. The Vitamins, Vol 2. New York: Academic Press, 1954: 132-223
9. DeLuca HF. Vitamin D-metabolism and function. In: Gross R, Grumbach MM, Labhart A et al. eds. Monographs on Endocrinology, Vol. 13. New York: Springer-Verlag, 1979: 1-78
10. Hunt RD, Garcia FG, Hegsted DM. Hypervitaminosis D in New World monkeys. Am J Clin Nutr 1969; 22: 358-366
11. Horst RL, Littledike ET, Riley JL, Napoli JL. Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal Bochem 1981; 116: 189-203
12. 3. J Am Vet Med Asstic 1983; 182: 1358-1369
13. Horst RL, Napoli JL, Littledike ET. Discrimination in the metabolism of orally dosed ergocalciferol and cholecalciferol by the pig, rat, and chick. Biochem J 1982; 204: 185-189
14. 3H] cholecalciferol by dairy calves. J Nutr 1983; 113: 2595-2600
15. Sjöden G, Lindgren JU, DeLuca HF. Antirachitic activity of 1α-hydroxyergocalciferol and 1α-hydroxycholecalciferol in rats. J Nutr 1984; 114: 2043-2046
16. 3 in the rat. Proc Soc Exp Biol Med 1985; 178: 432-436
17. Sato F, Ouchi Y, Okamoto Y et al. Effects of vitamin D2 analogs on calcium metabolism in vitamin D-deficient rats and in MC3T3 osteoblastic cells. Res Exp Med 1991; 191: 235-242
18. 2 on calcium metabolism in glucocorticoidtreated rats. Bone 1985; 6: 231-234
19. 2 on bone mass in ovariectomized rats. Calcif Tissue Int 1994; 54: 355 (Abstract)
20. 2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 1994; 9: 607-614
21. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled study. Ann Intern Med 1990; 113: 649-655
22. 3). Endocrinol Jpn 1985; 32: 305-315
23. 3. Bone Miner 1987; 3: 47-52
24. 2 in hemodialysis patients. J Am Soc Nephrol 1995; 6: 565 (Abstract)